Evaluation of vascular signal in pancreatic ductal carcinoma using contrast enhanced ultrasonography: Effect of systemic chemotherapy [3]

Gut

Volumn 54, Issue 7, 2005, Pages 1047-

  Kobayashi, A ^a   Yamaguchi, T ^a   Ishihara, T ^a   Tadenuma, H ^a   Nakamura, K ^a   Saisho, H ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE; PYRIMIDINE DERIVATIVE; SHU 508;

CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DRUG EFFECT; ECHOGRAPHY; HUMAN; IMAGE ANALYSIS; LETTER; PANCREAS CARCINOMA; PANCREAS DUCT CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, PANCREATIC DUCTAL; HUMANS; PANCREATIC NEOPLASMS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER;

EID: 21044439970     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.065789     Document Type: Letter

References (7)

1. Halm U, Schumann T, Schiefke I, et al. Decrease of CA19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer. Br J Cancer 2000;82:1013-16.
2. Micke O, Bruns F, Kurowski R, et al. Predictive value of carbohydrate antigen 19-9 in pancreatic cancer treated with radiochemotherapy. Int J Radiat Oncol Biol Phys 2003;57:90-7.
3. Ozawa Y, Numata K, Tanaka K, et al. Contrast-enhanced sonography of small pancreatic mass lesions. J Ultrasound Med 2002;21:983-91.
4. Nagase M, Furuse J, Ishii H, et al. Evaluation of contrast enhanced patterns in pancreatic tumors by coded harmonic sonographic imaging with a microbubble contrast agent. J Ultrasound Med 2003;22:789-95.
5. Takeda K, Goto H, Hirooka Y, et al. Contrast-enhanced transabdominal ultrasonography in the diagnosis of pancreatic mass lesions. Acta Radiol 2003;44:103-6.
6. Ohshima T, Yamaguchi T, Ishihara T, et al. Evaluation of blood flow in pancreatic ductal carcinoma using contrast-enhanced, wide-band Doppler ultrasonography: correlation with tumor characteristics and vascular endothelial growth factor. Pancreas 2004;28:335-43.
7. Kitano M, Kudo M, Maekawa K, et al. Dynamic imaging of pancreatic disease by contrast enhanced coded phase inversion harmonic ultrasonography. Gut 2004;53:854-9.